Fiche publication
Date publication
juillet 2022
Journal
International journal of molecular sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEVYS Didier
,
Dr TORA Laszlo
Tous les auteurs :
El-Saafin F, Devys D, Johnsen SA, Vincent SD, Tora L
Lien Pubmed
Résumé
Ubiquitin (ub) is a small, highly conserved protein widely expressed in eukaryotic cells. Ubiquitination is a post-translational modification catalyzed by enzymes that activate, conjugate, and ligate ub to proteins. Substrates can be modified either by addition of a single ubiquitin molecule (monoubiquitination), or by conjugation of several ubs (polyubiquitination). Monoubiquitination acts as a signaling mark to control diverse biological processes. The cellular and spatial distribution of ub is determined by the opposing activities of ub ligase enzymes, and deubiquitinases (DUBs), which remove ub from proteins to generate free ub. In mammalian cells, 1-2% of total histone H2B is monoubiquitinated. The SAGA (Spt Ada Gcn5 Acetyl-transferase) is a transcriptional coactivator and its DUB module removes ub from H2Bub1. The mammalian SAGA DUB module has four subunits, ATXN7, ATXN7L3, USP22, and ENY2. mouse embryos, lacking DUB activity, have a five-fold increase in H2Bub1 retention, and die at mid-gestation. Interestingly, embryos lacking the ub encoding gene, , have a similar phenotype. Here we provide a current overview of data suggesting that H2Bub1 retention on the chromatin in embryos may lead to an imbalance in free ub distribution. Thus, we speculate that ATXN7L3-containing DUBs impact the free cellular ub pool during development.
Mots clés
ATXN7L3, DUB, SAGA (Spt Ada Gcn5 acetyl-transferase), USP22, Ubc, embryos, histone H2B, monoubiquitylation, mouse, ubiquitin
Référence
Int J Mol Sci. 2022 07 5;23(13):